Assessment of the ovarian reserve with anti-Müllerian hormone in women who underwent allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning regimens or myeloablative regimens with ovarian shielding.Int J Hematol.(2016).
Comparison of graft-versus-host disease-free, relapse-free survival according to a variety of graft sources: antithymocyte globulin and single cord blood provide favorable outcomes in some subgroups.Haematologica.(2016).
Risk Factors and Impact of Secondary Failure of Platelet Recovery after Allogeneic Stem Cell Transplantation.Biol Blood Marrow Transplant.(2016).
Increased Mac-2 binding protein glycan isomer in patients at risk for late nonrelapse mortality after HSCT.Blood Adv3, 3287-3296.(2019).
A Prospective, Longitudinal Observation of the Incidence, Treatment, and Survival of Late Acute and Chronic Graft-versus-host disease by National Institutes of Health Criteria in a Japanese cohort.Biol Blood Marrow Transplant.(2019).